Abbott wins approval for hemoglobin test in Europe

05/13/2013 | RTT News

Abbott Laboratories has obtained CE mark approval to market its ARCHITECT clinical chemistry Hemoglobin A1c test in Europe. The blood assay, which measures an individual's average blood glucose level over the most recent three months, is intended to help doctors diagnose and monitor patients with diabetes, as well as identify those who may be at risk for developing the illness.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN